Reliq Health Technologies Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Reliq Health Technologies Inc

RHT.V 0.215

0.0%

Oct 28 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: pocotrader	4/11/2018 9:28:46 PM
	of 658

Reliq Health Technologies (RHT.V) – new analyst coverage themoneynarrative Company recommendations & reviews February 15, 2018 1 Minute In yet another sign of positive things to come for our favourite company, RHT.V, Beacon Securities Limited initiated coverage yesterday (February 14, 2018) with a $3.00 12-month target price. If the caption of their report serves as a summary of what you need to know (and themoneynarrative thinks it does), then “Monitor This Stock: Explosive Growth Ahead” should have investors pretty excited. Beacon Securities likes the investment thesis, and advises readers as follows: We believe the exponential increase in healthcare costs associated with managing at-home individuals with multiple chronic conditions has created the opportunity for Reliq to win significant market share with its remote patient monitoring software platform. With a slew of early wins and a very strong pipeline of opportunities, we believe the company is well positioned to show meaningful organic growth and operating leverage over our forecast period. Themoneynarrative agrees with their advice, although their $3.00 12-month target price is very conservative and likely will be revised upwards during 2018 with news of positive developments. We are particularly pleased that RHT.V is starting to make serious inroads with respect to investor awareness. Investors should expect additional analyst coverage in the months ahead. Institutional money is already helping provide significant positive share price momentum, and a $2.00+ share price is marginable (although some financial institutions set a higher threshold, typically $3.00). Themoneynarrative believes so strongly in RHT.V, that we suggest that the caption quoted above be amended to read: “Own This Stock for the Long Term: Explosive Growth Ahead”. Opportunities like this (as we have been saying for quite some time) don’t come along very often. Share this:

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next